Cellectar Biosciences Reports Financial Results for Year
Management to host a conference call today at 8:30 am ET...
Stay updated with breaking news from Nasdaq Clrb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Management to host a conference call today at 8:30 am ET...
FLORHAM PARK, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,670,000 shares, a growth of 208.6% from the December 31st total of 541,100 shares. Based on an average daily trading volume, of 1,130,000 […]
Iopofosine I 131 Active in Treating Malignancies in the Brain; Confirmed Response in CNS Lymphoma Provides Additional Validation for Continued Development...
Shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.58 and traded as high as $3.80. Cellectar Biosciences shares last traded at $3.70, with a volume of 2,579,009 shares trading hands. Analysts Set […]